Biomedicines (Dec 2023)

The Preserflo MicroShunt Affects Microvascular Flow Density in Optical Coherence Tomography Angiography

  • Jens Julian Storp,
  • Hannah Schatten,
  • Friederike Elisabeth Vietmeier,
  • Ralph-Laurent Merté,
  • Larissa Lahme,
  • Julian Alexander Zimmermann,
  • Verena Anna Englmaier,
  • Nicole Eter,
  • Viktoria Constanze Brücher

DOI
https://doi.org/10.3390/biomedicines11123254
Journal volume & issue
Vol. 11, no. 12
p. 3254

Abstract

Read online

Intraocular pressure (IOP) lowering surgery has been shown to alter microvascular density in glaucoma patients. The aim of this study is to report changes in retinal flow density (FD) over the course of treatment with the Preserflo MicroShunt, using optical coherence tomography angiography (OCTA). 34 eyes from 34 patients who underwent Preserflo MicroShunt implantation were prospectively enrolled in this study. OCTA imaging was conducted at the superficial (SCP), deep (DCP) and radial peripapillary plexus (RPC) levels. The progression of FD and IOP was assessed at different time points from baseline to six months postoperatively for the entire patient population, as well as disease severity subgroups. The Preserflo MicroShunt achieved a significant reduction in IOP over the course of six months (median: 8 mmHg; p p < 0.01). The decrease in peripapillary FD was strongest in patients with advanced glaucoma (median: −3.58). These observations hint towards dysfunctional autoregulatory mechanisms in capillaries surrounding the optic nerve head in advanced glaucoma. In comparison, the microvascular structure of the macula appeared more resilient to changes in IOP.

Keywords